T Cell Targeted Strategies for Improved Efficacy and Safety of Specific Immunotherapy for Allergic Disease

E-ISSN： 1875-614x|12|3|201-222

ISSN： 1871-5230

Source： Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol.12, Iss.3, 2013-12, pp. : 201-222

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

T Cell Targeted Allergen Derivatives for Improved Efficacy and Safety of Specific Immunotherapy for Allergic Disease

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 2, Iss. 4, 2003-12 ,pp. : 351-365

Bentham Science Publishers

Access to resources Recommend Favorite

The Safety and Efficacy of Desloratadine for the Management of Allergic Disease

By Berger William E.

Drug Safety, Vol. 28, Iss. 12, 2005-01 ,pp. : 1101-1118

Adis International

Access to resources Recommend Favorite

An Overview of Immunotherapy for Allergic Disease: New Developments and Future Strategies

Medicinal Chemistry Reviews - Online, Vol. 1, Iss. 2, 2004-04 ,pp. : 163-177

Bentham Science Publishers

Access to resources Recommend Favorite

Immunotherapy approach to allergic disease

By Fick R.B. Fox J.A. Jardieu P.M.

Immunopharmacology, Vol. 48, Iss. 3, 2000-07 ,pp. : 307-310

Elsevier

Access to resources Recommend Favorite

Preclinical Evaluation of Efficacy and Safety of an Improved Lentiviral Vector for the Treatment of &bgr;-Thalassemia and Sickle Cell Disease

Current Gene Therapy, Vol. 15, Iss. 1, 2015-02 ,pp. : 64-81

Bentham Science Publishers

Access to resources Recommend Favorite